Rami Kahwash, MD
Advanced Heart Failure and Transplant Cardiology · Columbus, OHNPI 1053515718
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Impulse Dynamics (USA) Inc. accounts for 84.5% of it on its own, with 8 other manufacturers making up the rest. Among advanced heart failure and transplant cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $1478.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Impulse Dynamics (USA) Inc.$320K
- Edwards Lifesciences$30K
- Medtronic$17K
- Bayer$8K
- Scpharmaceuticals Inc.$4K
- AstraZeneca$135
- plus $140 from 3 others
Across 139 payments — averaging $5142.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$456K
- Medtronic$174K
- Endotronix, Inc.$73K
- Cvrx, Inc.$11K
What the payments were for
- Consulting fees$204,31054%
- Speaking & faculty fees$142,95038%
- Travel & lodging$24,0386%
- Food & beverage$7,2512%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 174 | $320,002 |
| Edwards Lifesciences | 16 | $29,726 |
| Medtronic(2 entities) | 52 | $16,847 |
| Bayer | 7 | $7,714 |
| Scpharmaceuticals Inc. | 2 | $4,000 |
| AstraZeneca | 2 | $135 |
| Bridgebio Pharma, Inc. | 1 | $100 |
| Abiomed | 1 | $24 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMIZER$489,000
- OPTIMIZER SMART SYSTEM$68,430
- Kerendia$7,498
- FUROSCIX$4,000
- Reveal LINQ$1,659
- LINQ II$237
- AIRSUPRA$121
- Attruby$100
How this compares
$378,563 in reported general payments places this provider in the 95th percentile of 62 advanced heart failure and transplant cardiology providers in Ohio.
See all advanced heart failure and transplant cardiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 37 | $1,078,000 |
| EntrestoSacubitril/Valsartan | 299 | $381,904 |
| FarxigaDapagliflozin Propanediol | 163 | $176,274 |
| JardianceEmpagliflozin | 141 | $168,407 |
| EliquisApixaban | 101 | $122,509 |
| XareltoRivaroxaban | 21 | $17,274 |
| Mycophenolate Mofetil | 83 | $7,158 |
| Eplerenone | 76 | $6,286 |
| Tacrolimus | 79 | $5,078 |
| Sirolimus | 14 | $3,931 |
| Metoprolol Succinate | 211 | $3,334 |
| Carvedilol | 177 | $1,928 |
| Rosuvastatin Calcium | 132 | $1,519 |
| Nifedipine ErNifedipine | 13 | $1,445 |
| Niacin ErNiacin | 14 | $1,386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $135 | $176,274163 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 62 advanced heart failure and transplant cardiology providers in Ohio.
Other advanced heart failure and transplant cardiology in Columbus
- William AbrahamColumbus$802K
- Beth ForemanColumbus$28K
- Vaiibhav PatelColumbus$10K
- Ray HershbergerColumbus$6K
- Anupam BasurayColumbus$6K
- Ajay VallakatiColumbus$4K
- Katherine DoddColumbus$4K
- Lindsay CastleColumbus$3K
- Rodolfo Denadai BenattiColumbus$2K
- Yaquta KakaColumbus$859
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.